» Articles » PMID: 28444579

The Gut, Its Microbiome, and Hypertension

Overview
Date 2017 Apr 27
PMID 28444579
Citations 67
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose Of The Review: Evidence is rapidly accumulating implicating gut dysbiosis in hypertension (HTN). However, we are far from understanding whether this is a cause or consequence of HTN, and how to best translate this fundamental knowledge to advance the management of HTN. This review aims to summarize recent advances in the field, illustrate the connections between the gut and hypertension, and establish that the gut microbiota (GM)-gut interaction is centrally positioned for consideration as an innovative approach for HTN therapeutics.

Recent Findings: Animal models of HTN have shown that gut pathology occurs in HTN, and provides some clues to mechanisms linking the dysbiosis, gut pathology, and HTN. Circumstantial evidence links gut dysbiosis and HTN. Gut pathology, apparent in animal HTN models, has not been fully investigated in hypertensive patients. Objective evidence and an understanding of mechanisms could have a major impact for new antihypertensive therapies and/or improved applications of current ones.

Citing Articles

The differences in intestinal flora and metabolites between H-type hypertension and non-H-type hypertension.

Wu J, Zhao J, Cheng Y, Zhou H, Shen G, Ding H J Transl Med. 2025; 23(1):329.

PMID: 40087692 DOI: 10.1186/s12967-025-06295-8.


Bioelectrical impedance analysis predicts prehypertension and hypertension: A hospital-based cross-sectional study.

Yogesh M, Mody M, Patel J, Shah S, Makwana N, Nagda J J Family Med Prim Care. 2024; 13(10):4336-4342.

PMID: 39629404 PMC: 11610864. DOI: 10.4103/jfmpc.jfmpc_408_24.


The Microbial Perspective: A Systematic Literature Review on Hypertension and Gut Microbiota.

Tsiavos A, Antza C, Trakatelli C, Kotsis V Nutrients. 2024; 16(21).

PMID: 39519531 PMC: 11547301. DOI: 10.3390/nu16213698.


Characteristics of gut microbiota and serum metabolism in patients with atopic dermatitis.

Zeng Y, Fan N, Gu X, Zhang Y, Min W, Mao Q Skin Res Technol. 2024; 30(7):e13792.

PMID: 38940462 PMC: 11212066. DOI: 10.1111/srt.13792.


Perspectives on the involvement of the gut microbiota in salt-sensitive hypertension.

Mu Y, Gao Z, Mao Z, Pan S, Liu D, Liu Z Hypertens Res. 2024; 47(9):2351-2362.

PMID: 38877311 DOI: 10.1038/s41440-024-01747-y.


References
1.
Xiao F, Zimpelmann J, Burger D, Kennedy C, Hebert R, Burns K . Protein Kinase C-δ Mediates Shedding of Angiotensin-Converting Enzyme 2 from Proximal Tubular Cells. Front Pharmacol. 2016; 7:146. PMC: 4887483. DOI: 10.3389/fphar.2016.00146. View

2.
Vighi G, Marcucci F, Sensi L, Di Cara G, Frati F . Allergy and the gastrointestinal system. Clin Exp Immunol. 2008; 153 Suppl 1:3-6. PMC: 2515351. DOI: 10.1111/j.1365-2249.2008.03713.x. View

3.
Granger D, Holm L, Kvietys P . The Gastrointestinal Circulation: Physiology and Pathophysiology. Compr Physiol. 2015; 5(3):1541-83. DOI: 10.1002/cphy.c150007. View

4.
Tang W, Wang Z, Kennedy D, Wu Y, Buffa J, Agatisa-Boyle B . Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease. Circ Res. 2015; 116(3):448-55. PMC: 4312512. DOI: 10.1161/CIRCRESAHA.116.305360. View

5.
Erny D, Hrabe de Angelis A, Jaitin D, Wieghofer P, Staszewski O, David E . Host microbiota constantly control maturation and function of microglia in the CNS. Nat Neurosci. 2015; 18(7):965-77. PMC: 5528863. DOI: 10.1038/nn.4030. View